MiMedx
Price & Volume
Stats
See more52W Range | $3.81-$7.99 |
Market Cap | $566M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $418.6M |
Revenue Growth (YoY) | 27.1% |
Gross Profit (12 Mos) | $345.6M |
Diluted EPS | $0.32 |
News
See moreYahoo Finance • last month
MiMedx targets $340M–$360M 2026 revenue while navigating reimbursement changes and boosting surgical growth
Yahoo Finance • last month
Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading Companies - Gilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More
Yahoo Finance • 3 months ago
Organogenesis drops as Medicare to pull skin substitute LCDs (update)
Yahoo Finance • 5 months ago
MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule
About
CEO | Mr. Joseph H. Capper |
Address | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 808 |
